M. Pharmacy Revised Syllabus To Be Implemented Form 2013-2014
BAccreditated by NAAC(2009)Revised Syllabus forMaster of PHARMACYI and IInd Year(Sem. I to IV)Syllabus to be implemented from June 2013 onwards1 Page
A] Ordinance and Regulations(FOR DEGREE OF MASTER OF PHARMACY IN THE IN THE FACULTY OFENGINEERING & ---B] Shivaji University, KolhapurRevised Syllabus ForMASTER OF PHARMACY1. TITLE: MASTER OF PHARMACY IN,1.1 Pharmaceutical Chemistry1.2 Biopharmaceutics1.3 Pharmaceutics1.4 Quality Assurance*1.5 Pharmacology1.6 Pharmacognosy1.7 Pharmaceutical Technology1.8 Pharmaceutical Analysis1.9 Quality Assurance Techniques*2.0 Pharmaceutics Drug Regulatory Affairs* The course structure, examination scheme and syllabus is same.Under the Faculty of ENGINEERING & TECHNOLOGY2. YEAR OF IMPLEMENTATION: - Revised Syllabi will be implemented from June2013 onwards.3. PREAMBLE:Amongst the health care professionals, pharmacists are considered as major pillarsin design, development and supply of quality medicines to the patients. Thedevelopment of pharmaceuticals/formulations is an outcome of interplay betweenpharmaceutical and medicinal chemistry (especially synthetic and phytochemistry),pharmaceutics and pharmaceutical technologies, analytical techniques and qualityassurance at each and every level. Along with the basics of drug discovery anddevelopment, the advanced tools assisting developments of new drug substancesand drug products are of paramount importance. Especially, high throughputscreening techniques accelerate the pace of API/ excipient developments. Thepharmaceuticals which are being developed needs to be guaranteed high degree ofquality assurance in it. Simultaneously, to meet the global and diverse needs onehas to address requirements of both regulatory and non regulatory markets.2 Page
4. GENERAL OBJECTIVES OF THE COURSE (MASTER OF PHARMACY)1) To understand the drug discovery and development process to enable addition ofnew drug molecules in the field of pharmaceutical sciences2) Understanding physico-chemical and biological science of drugs/actives andinactives in design of pharmaceutical formulations.3) Assuring design of quality pharmaceutical formulations offering improved patientcompliance and therapeutic efficacy.4) To understand techniques and technologies used to manufacture drugs/formulations,and ensure the quality of product by exercising quality assurance tools, in particularanalytics.5) To update the students about the regulatory requirements of pre and postmanufacturing of drugs, including post marketing issues.6) The students shall be envisioned to derive new chemical entities/molecules, drugsubstances and formulate in to therapeutically efficient dosage forms and meet theever changing requirements of diverse diseases and disorders in patients acrossglobe5. DURATIONMaster of Pharmacy (M. Pharm) is a full time course.The duration of Master of Pharmacy Course is of two Years, divided into four semesters.6. PATTERN:Pattern of Examination will be Semester type.7. FEE STRUCTURE:The Tuition fees, other fees and deposits like Library and Laboratory will be asprescribed by the Shikshan Shulka Samitee, D.T.E., University, from time to time.8. ADMISSIONS TO M. PHARM. COURSE:The admission to M. Pharm Course will be given as per guidelines of Directorate ofTechnical Education, Mumbai & A.I.C.T.E., New Delhi.The admitted candidate will have to strictly abide by the rules and regulations prescribedby the A.I.C.T.E., D.T.E and the University.The seats will be allotted to the different categories of the candidates as per the guidelinesof D.T.E., A.I.C.T.E. and the University.9. ELIGIBILITY FOR ADMISSION:The candidate seeking admission to M. Pharm. Course must have:For Non-Sponsored category of studentsAdmission to fulltime M. Pharm. Course for non-sponsored category of studentsshould be made through GPAT/ CET. When the GPAT/ CET Qualified students are notavailable, the admission may be given to non GPAT/ CET candidates on Merit who have3 Page
passed B. Pharm. degree examination of any statuary/recognized University with at least50% of aggregate marks or equivalent grade (45% of marks for SC/ST candidates)For Sponsored category of studentsThe candidates who possess Bachelors degree in Pharmacy from AICTE approvedinstitutions with at least 50% marks or equivalent grade (45 % marks for those who areteachers in pharmacy college or polytechnic)10. MEDIUM OF INSTRUCTION:The medium of instruction shall be in English4 Page
11. STRUCTURE OF COURSE:M. PHARM COURSE STRUCTUREPHARMACEUTICAL CHEMISTRYFIRST YEAR (SEMESTER I/II) (NO OF PAPERS: ernalTotalMarksTheorySubject/PapersMATModern Analytical Techniques (Common)80208020200APC-IAdvanced Pharmaceutical Chemistry- I80208020200DDDDrug Design and Development8020--100ELE-IElective – I8020--100 Seminar*IIPracticalRMBAPC-IIAOCELE-IIA / A / B / C / D/ F--Research WorkMonitoring and record keeping--Group discussionMonitoring and record keeping--Research Methodology & Biostatistics (Common)80208020200Advanced Pharmaceutical Chemistry- II80208020200Advanced Organic Chemistry8020--100Elective-II8020--100 Seminar*A / A / B / C / D/ F--Research WorkMonitoring and record keeping--Group discussionMonitoring and record keeping--Total (Sem I & II)8005 Page4001200
M. PHARM COURSE STRUCTUREPHARMACEUTICAL CHEMISTRYSECOND YEAR (SEMESTER persExternalResearch proposal/synopsis preparation,Research proposal presentation and viva vocePracticalInternal----ExternalInternal--A / A / B /C / D/ FA / A / B / C / D/ FTHESIS Colloquium*----150--Defence (viva voce)--50--Total (Sem III & IV)--200GRAND TOTAL ( Sem I to IV)6 Page---Research and Dissertation* The seminar / colloquium shall carry 50 marksTotalMarks2002001400
M. PHARM COURSE STRUCTUREBIOPHARMACEUTICSFIRST YEAR (SEMESTER I/II) (NO OF PAPERS: lInternalExternalInternalTotalMarksMATModern Analytical Techniques (Common)80208020200ABP-IAdvanced Biopharmaceutics- I80208020200Pharmacokinetics8020--100Elective – I8020--100PKELE-I Seminar*IIPracticalRMBA / A / B / C / D/ F--Research WorkMonitoring and record keeping--Group discussionMonitoring and record keeping--Research Methodology & Biostatistics (Common)80208020200ABP-IIAdvanced Biopharmaceutics- II80208020200RNDDSRecent Advances in Novel Drug A / A / B / C / D/ F--Research WorkMonitoring and record keeping--Group discussionMonitoring and record keeping--Seminar*Total (Sem I & II)8007 Page4001200
M. PHARM COURSE STRUCTUREBIOPHARMACEUTICSSECOND YEAR (SEMESTER persExternalResearch proposal/synopsis preparation,Research proposal presentation and viva vocePracticalInternal----ExternalInternal--A / A / B /C / D/ FA / A / B / C / D/ FTHESIS Colloquium*----150--Defence (viva voce)--50--Total (Sem III & IV)--200GRAND TOTAL ( Sem I to IV)8 Page---Research and Dissertation* The seminar / colloquium shall carry 50 marksTotalMarks2002001400
M. PHARM COURSE STRUCTUREPHARMACEUTICSFIRST YEAR (SEMESTER I/II) (NO OF PAPERS: lInternalExternalInternalTotalMarksMATModern Analytical Techniques (Common)80208020200AP-IAdvanced Pharmaceutics- I80208020200DDDFDesign and Development of Dosage Forms8020--100ELE-IElective – I8020--100A / A / B / C / D/ F--Research WorkMonitoring and record keeping--Group discussionMonitoring and record keeping--Seminar*IIPracticalRMBResearch Methodology & Biostatistics (Common)80208020200AP-IIAdvanced Pharmaceutics- II80208020200BPKBiopharmaceutics and IA / A / B / C / D/ F--Research WorkMonitoring and record keeping--Group discussionMonitoring and record keeping--Seminar*Total (Sem I & II)8009 Page4001200
M. PHARM COURSE STRUCTUREPHARMACEUTICSSECOND YEAR (SEMESTER --A / A / B / C/D/ F------Research proposal/synopsis preparation,Research proposal presentation and viva voceTHESIS Colloquium*PracticalA / A / B / C / D/ FResearch and Dissertation--150--Defence (viva voce)--50--Total (Sem III & IV)--200GRAND TOTAL ( Sem I to IV)* The seminar / colloquium shall carry 50 marks10 P a g e2002001400
M. PHARM COURSE STRUCTUREQUALITY ASSURANCEFIRST YEAR (SEMESTER I/II) (NO OF PAPERS: ernalTotalMarksTheorySubject/PapersMATModern Analytical Techniques (Common)80208020200QAT-IQuality Assurance Techniques - I80208020200DRIPRDrug Regulatory Affairs and Intellectual PropertyRights8020--100ELE-IElective – I8020--100 A / A / B / C / D/ F--Research WorkMonitoring and record keeping--Group discussionMonitoring and record keeping--Seminar*IIPracticalRMBResearch Methodology & Biostatistics (Common)8020802020080208020200Quality Management and Audit8020--100Elective-II8020--100QAT- II Quality Assurance Techniques - IIQMAELE-IIA / A / B / C / D/ F--Research WorkMonitoring and record keeping--Group discussionMonitoring and record keeping--Seminar*Total (Sem I & II)80011 P a g e4001200
M. PHARM COURSE STRUCTUREQUALITY ASSURANCESECOND YEAR (SEMESTER --A / A / B / C /D/ F------Research proposal/synopsis preparation,Research proposal presentation and viva voceTHESIS Colloquium*PracticalA / A / B / C / D/ FResearch and Dissertation--150--Defence (viva voce)--50--Total (Sem III & IV)--200GRAND TOTAL ( Sem I to IV)* The seminar / colloquium shall carry 50 marks12 P a g e2002001400
M. PHARM COURSE STRUCTUREPHARMACOLOGYFIRST YEAR (SEMESTER I/II) (NO OF PAPERS: arksModern Analytical Techniques (Common)80208020200Advanced Pharmacology - I80208020200NDDPNew Drug Development Process8020--100ELE-IElective – A / A / B / C / D/ F--Research WorkMonitoring and record keeping--Group discussionMonitoring and record earch Methodology & Biostatistics (Common)80208020200Advanced Pharmacology - II80208020200Safety Pharmacology and Toxicology8020--100Elective-II8020--100A / A / B / C / D/ F--Research WorkMonitoring and record keeping--Group discussionMonitoring and record keeping--Seminar*Total (Sem I & II)80013 P a g e4001200
M. PHARM COURSE STRUCTUREPHARMACOLOGYSECOND YEAR (SEMESTER --A / A / B / C /D/ F------Research proposal/synopsis preparation,Research proposal presentation and viva voceTHESIS Colloquium*PracticalA / A / B / C / D/ FResearch and Dissertation--150--Defence (viva voce)--50--Total (Sem III & IV)--200GRAND TOTAL ( Sem I to IV)* The seminar / colloquium shall carry 50 marks14 P a g e2002001400
M. PHARM COURSE STRUCTUREPHARMACOGNOSYFIRST YEAR (SEMESTER I/II) (NO OF PAPERS: arksModern Analytical Techniques (Common)80208020200Advanced Pharmacognosy - I80208020200Herbal Drug Formulations8020--100Elective – t/PapersA / A / B / C / D/ F--Research WorkMonitoring and record keeping--Group discussionMonitoring and record keeping--Seminar*IIPracticalResearch Methodology & Biostatistics (Common)80208020200Advanced Pharmacognosy - II80208020200RCOGRecent Advances in BACOG-IIA / A / B / C / D/ F--Research WorkMonitoring and record keeping--Group discussionMonitoring and record keeping--Total (Sem I & II)800Seminar*15 P a g e4001200
M. PHARM COURSE STRUCTUREPHARMACOGNOSYSECOND YEAR (SEMESTER --A / A / B / C /D/ F------Research proposal/synopsis preparation,Research proposal presentation and viva voceTHESIS Colloquium*PracticalA / A / B / C / D/ FResearch and Dissertation--150--Defence (viva voce)--50--Total (Sem III & IV)--200GRAND TOTAL ( Sem I to IV)* The seminar / colloquium shall carry 50 marks16 P a g e2002001400
M. PHARM COURSE STRUCTUREPHARMACEUTICAL TECHNOLOGYFIRST YEAR (SEMESTER I/II) (NO OF PAPERS: ernalTotalMarksTheorySubject/PapersMATModern Analytical Techniques (Common)80208020200APT-IAdvanced Pharmaceutical Technology- I80208020200Technology Transfer8020--100Elective – I8020--100TTELE-IA / A / B / C / D/ F--Research WorkMonitoring and record keeping--Group discussionMonitoring and record keeping--Seminar*IIPracticalRMBAPT-IIResearch Methodology & Biostatistics (Common)80208020200Advanced Pharmaceutical Technology- II802080202008020--1008020--100BPBME Biopharmaceutics and Biomedical EngineeringELE-IIElective-IIA / A / B / C / D/ F--Research WorkMonitoring and record keeping--Group discussionMonitoring and record keeping--Total (Sem I & II)800Seminar*17 P a g e4001200
M. PHARM COURSE STRUCTUREPHARMACEUTICAL TECHNOLOGYSECOND YEAR (SEMESTER --A / A / B / C /D/ F------Research proposal/synopsis preparation,Research proposal presentation and viva voceTHESIS Colloquium*PracticalA / A / B / C / D/ FResearch and Dissertation--150--Defence (viva voce)--50--Total (Sem III & IV)--200GRAND TOTAL ( Sem I to IV)* The seminar / colloquium shall carry 50 marks18 P a g e2002001400
M. PHARM COURSE STRUCTUREPHARMACEUTICAL ANALYSISFIRST YEAR (SEMESTER I/II) (NO OF PAPERS: ernalTotalMarksTheorySubject/PapersMATModern Analytical Techniques (Common)80208020200APA-IAdvanced Pharmaceutical Analysis- I80208020200Analytical Instrumentation and Technology8020--100Elective – I8020--100AITELE-IA / A / B / C / D/ F--Research WorkMonitoring and record keeping--Group discussionMonitoring and record keeping--Seminar*IIPracticalResearch Methodology & Biostatistics (Common)80208020200APA-IIAdvanced Pharmaceutical Analysis- II80208020200FBCAFood, Biologicals and Cosmetic Analysis8020--100ELE-IIElective-II8020--100RMBA / A / B / C / D/ F--Research WorkMonitoring and record keeping--Group discussionMonitoring and record keeping--Total (Sem I & II)800Seminar*19 P a g e4001200
M. PHARM COURSE STRUCTUREPHARMACEUTICAL ANALYSISSECOND YEAR (SEMESTER --A / A / B / C /D/ F------Research proposal/synopsis preparation,Research proposal presentation and viva voceTHESIS Colloquium*PracticalA / A / B / C / D/ FResearch and Dissertation--150--Defence (viva voce)--50--Total (Sem III & IV)--200GRAND TOTAL ( Sem I to IV)* The seminar / colloquium shall carry 50 marks20 P a g e2002001400
M. PHARM COURSE STRUCTUREQUALITY ASSURANCE TECHNIQUESFIRST YEAR (SEMESTER I/II) (NO OF PAPERS: ernalTotalMarksTheorySubject/PapersMATModern Analytical Techniques (Common)80208020200QAT-IQuality Assurance Techniques - I80208020200DRIPRDrug Regulatory Affairs and Intellectual PropertyRights8020--100ELE-IElective – I8020--100 A / A / B / C / D/ F--Research WorkMonitoring and record keeping--Group discussionMonitoring and record keeping--Seminar*IIPracticalRMBResearch Methodology & Biostatistics (Common)8020802020080208020200Quality Management and Audit8020--100Elective-II8020--100QAT- II Quality Assurance Techniques-IIQMAELE-IIA / A / B / C / D/ F--Research WorkMonitoring and record keeping--Group discussionMonitoring and record keeping--Total (Sem I & II)800Seminar*21 P a g e4001200
M. PHARM COURSE STRUCTUREQUALITY ASSURANCE TECHNIQUESSECOND YEAR (SEMESTER --A / A / B / C /D/ F------Research proposal/synopsis preparation,Research proposal presentation and viva voceTHESIS Colloquium*PracticalA / A / B / C / D/ FResearch and Dissertation--150--Defence (viva voce)--50--Total (Sem III & IV)--200GRAND TOTAL ( Sem I to IV)* The seminar / colloquium shall carry 50 marks22 P a g e2002001400
M. PHARM COURSE STRUCTUREPHARMACEUTICS DRUG REGULATORY AFFAIRSFIRST YEAR (SEMESTER I/II) (NO OF PAPERS: nalInternalMATModern Analytical Techniques (Common)80208020200DRA-IDrug Regulatory Affairs - I80208020200Development of Dosage forms8020--100Elective – I8020--100DDFELE-IA / A / B / C / D/ F--Research WorkMonitoring and record keeping--Group discussionMonitoring and record rsResearch Methodology & Biostatistics (Common)80208020200DRA-IIDrug Regulatory Affairs - II80208020200NDDSNovel Drug Delivery Systems8020--100ELE-IIElective-II8020--100RMBA / A / B / C / D/ F--Research WorkMonitoring and record keeping--Group discussionMonitoring and record keeping--Total (Sem I & II)800Seminar*23 P a g e4001200
M. PHARM COURSE STRUCTUREPHARMACEUTICS DRUG REGULATORY AFFAIRSSECOND YEAR (SEMESTER search proposal/synopsis preparation,Research proposal presentation and viva voceTHESIS alExternalInternal------A / A / B / C /D/ F------A / A / B / C / D/ FResearch and Dissertation--150--Defence (viva voce)--50--Total (Sem III & IV)--200GRAND TOTAL ( Sem I to IV)* The seminar / colloquium shall carry 50 marks24 P a g e2002001400
12. SCHEME OF TEACHING AND EXAMINATIONM. PHARM (PHARMACEUTICAL CHEMISTRY)FIRST YEAR / (SEMESTER – I/ II)Teaching SchemeExamination ct/paperSemesterCodeExternal Internal External InternalLecture Tutorial Practical TotalHo Ma Ho Ma Ho Ma Ho Maurs rks urs rks urs rks urs rksAnalytical TechniquesI03-06093801 206803 20MAT Modern(Common)Advanced PharmaceuticalAPC-I03-06093801 206803 20Chemistry - IDDD Drug Design and Development0201-033801 20-ELE-I Elective – I0201-033801 20-Seminar*One per student-A / A / B / C / D / FResearch Work--0909--Group discussion03(01 01 01)03Monitoring and record 3-0609380120680320RMBBiostatistics (Common)03-0609380120680320APC-II Advanced PharmaceuticalChemistry - IIAOC Advanced Organic Chemistry0201-03380120-ELE-II Elective-II0201-03380120-Seminar*One per student-A / A / B / C / D / FResearch Work--0909--Group discussion03(01 01 01)03Monitoring and record keepingTotal100224@36400200Total (Sem I & II)200448@7280040025 P a g eTotal200200100100---600200200---6001200
M. PHARM (PHARMACEUTICAL CHEMISTRY)SECOND YEAR / SEMESTER – III/IVSemesterSubjectCodeTeaching VResearch proposal/synopsis preparation,Research proposal presentation and vivavoceTotalColloquium*Tutorial PracticalExamination Scheme(Marks)TotalTheoryPracticalExternal Internal--A / A /B/C/D/FTotal------3636-----One per student3636---- A /A/B/C/D/FResearch and Dissertation----3636--150--Defence (viva voce)----------50--Total----3636--200200Total (Sem III & IV)----7272--200200GRAND TOTAL: Sem I to IV@* The seminar / colloquium shall carry 50 marks; Hours including group discussion.26 P a g e--2001400
M. PHARM (BIOPHARMACEUTICS)FIRST YEAR / (SEMESTER – I/ II)Teaching rModern AnalyticalTechniques (Common)ABP-I AdvancedBiopharmaceutics- IPKPharmacokineticsELE-I Elective – ISeminar*Research WorkGroup discussionTotalRMBResearch Methodology &Biostatistics (Common)ABP-II AdvancedBiopharmaceutics- IIAdvances i
Revised Syllabus for Master of PHARMACY I and IInd Year (Sem. I to IV) Syllabus to be implemented from June 2013 onwards. . B] Shivaji University, Kolhapur Revised Syllabus For MASTER OF PHARMACY 1. TITLE: MASTER OF PHARMACY IN, 1.1 Pharmaceutical Chemistry 1.2 Biopharmaceutics 1.3 Pharmaceutics . Mumbai & A.I.C.T.E., New Delhi.
Student Training Manual/Workbook . 5 Law Enforcement/Criminal Justice Use Only Revised 5/23/2016 Revised By: Revised Date: Revised By: Revised Date: Revised By: Revised Date: Revised By: Revised Date: Revised By: Revised Date: Revised By: Revised Date: Revised By: Revised Date: Marie Jernigan Supervisor Training Unit SBI Criminal Information and Identification Section May 23, 2016 Jeannie .
Pharmacy Automation Supplies (PAS) Pharmacy Cure All, LLC (PCA) Pharmacy Development Services Pharmacy First Pharmacy Quality Solutions Pharmacy Technician Certification Board Pharmacy Times Pharmacy-Lite Packaging PharmPilot, Inc. PharmSaver LLC Pharmsource, LLC. Physician 360
Oct 14, 2009 · MM. CVS/pharmacy #9838 – Sun Valley NN. CVS/pharmacy #9840 – Reno OO. CVS/pharmacy #9841 – Reno PP. CVS/pharmacy #9842 – Carson City QQ. CVS/pharmacy #9843 – Fallon . Advanced Care Rx Pharmacy – Las Vegas CC. Prime Pharmacy – Henderson DD. Spring Valley Surgery Center
cigna medical group pharmacy - san tan 78 3530 south val vista drive, suite 101 cigna medical group pharmacy - scottsdale 58 7287 e earll dr, bldg d cigna medical group pharmacy - south mountain 56 7236 s central ave cigna medical group pharmacy - stapley 63 1840 s stapley dr, ste 101 cigna medical group pharmacy - sun city 53 9069 w thunderbird rd
The Emergence of Modern Pharmacist Roles The Modern Pharmacy William Procter Jr. is considered the father of American pharmacy. He graduated from the Philadelphia College of Pharmacy in 1837. In addition to having operated a retail pharmacy, Procter was a professor of pharmacy for 20 years at the college from which he graduated.
OPJS UNIVERSITY, CHURU (RAJASTHAN) * Syllabus: Bachelor of Pharmacy OPJS UNIVERSITY, CHURU Pharmacy Council of India New Delhi Draft Rules & Syllabus for the Bachelor of Pharmacy (B. Pharm) Course [Framed under Regulation 6, 7 & 8 of the Bachelor of Pharmacy (B. Pharm) course regulations 2014] .
[Syllabus for Diploma in Pharmacy (D. Pharm) Course] Chapter 1:- PHARMACY COUNCIL OF INDIA EDUCATION REGULATIONS, 1991 FOR THE DIPLOMA COURSE IN PHARMACY Regulations framed under section 10 of the Pharmacy Act, 1948. (As approved by the Government of India, Ministry of Health vide, letter No V. 13016/1/89-PMS dt.
Jonathan Sutherland-Cropper 1971 Alison Summers 1971 Dinah Stehr 1971 Matthew Simpson 1971 Christine Ryan 1971 . Frances Anne Hutchinson 1971 John Homann 1971 David Hill 1971 Richard Hield 1971 Robert Haydon 1971 Lynette Harrison 1971 Michael Harris 1971 Diana Hardwicke 1971 Piers Harden 1971 John Handmer 1971 Anne Hamilton 1971 Tom Hall 1971 Peter Greed 1971 Margaret Gray 1971
